Stay updated on Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the page's revision log.
    Difference
    0.1%
    Check dated 2026-03-25T20:28:44.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T13:36:51.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 was added and Revision: v3.4.1 was removed. These are global UI/operational updates and do not modify study details or records on the page.
    Difference
    0.4%
    Check dated 2026-02-11T01:57:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH operating status. Updated the page version from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:57:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows a glossary toggle and includes updated labels in the Study Record Dates and footer, such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-27T21:41:13.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The study's location information was reorganized under a new Locations section with California and Oregon listed within it, replacing the previous separate California Locations and Oregon Locations sections. The revision number was updated to v3.3.3 and the HHS Vulnerability Disclosure footer was removed.
    Difference
    0.3%
    Check dated 2025-12-23T07:42:46.000Z thumbnail image

Stay in the know with updates to Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page.